| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adolescents key to achieving HIV control targets in Uganda
|
Nakkazi, Esther
|
|
|
5 |
12 |
p. e681-e682
|
artikel
|
| 2 |
Birth HIV testing and paediatric treatment programmes
|
Goga, Ameena
|
|
|
5 |
12 |
p. e675-e676
|
artikel
|
| 3 |
Children affected by HIV need a holistic approach to care
|
The Lancet HIV,
|
|
|
5 |
12 |
p. e671
|
artikel
|
| 4 |
Delays and gaps in HIV programmes in Pakistan
|
Altaf, Arshad
|
|
|
5 |
12 |
p. e678-e679
|
artikel
|
| 5 |
Digital health to support early infant diagnosis of HIV
|
Lester, Richard T
|
|
|
5 |
12 |
p. e673-e674
|
artikel
|
| 6 |
Evaluation of the HIV Infant Tracking System (HITSystem) to optimise quality and efficiency of early infant diagnosis: a cluster-randomised trial in Kenya
|
Finocchario-Kessler, Sarah
|
|
|
5 |
12 |
p. e696-e705
|
artikel
|
| 7 |
Highlights of HIV Drug Therapy 2018
|
Hayward, Peter
|
|
|
5 |
12 |
p. e684
|
artikel
|
| 8 |
Highlights of HIVR4P 2018
|
Zuccala, Elizabeth
|
|
|
5 |
12 |
p. e683
|
artikel
|
| 9 |
Issues about periconception use of dolutegravir are reminiscent of early concerns about efavirenz
|
Black, Vivian
|
|
|
5 |
12 |
p. e732-e736
|
artikel
|
| 10 |
Long-lasting HIV suppression by combined immunotherapy
|
Jaworski, Juan P
|
|
|
5 |
12 |
p. e680
|
artikel
|
| 11 |
12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study
|
Technau, Karl-Günter
|
|
|
5 |
12 |
p. e706-e714
|
artikel
|
| 12 |
Naguru Teenage Information and Health Centre
|
Nakkazi, Esther
|
|
|
5 |
12 |
p. e685
|
artikel
|
| 13 |
National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis
|
Tippett Barr, Beth A
|
|
|
5 |
12 |
p. e688-e695
|
artikel
|
| 14 |
Outcomes in children on raltegravir: a story of two halves
|
Collins, Intira Jeannie
|
|
|
5 |
12 |
p. e676-e678
|
artikel
|
| 15 |
Preventive and therapeutic features of broadly neutralising monoclonal antibodies against HIV-1
|
Jaworski, Juan P
|
|
|
5 |
12 |
p. e723-e731
|
artikel
|
| 16 |
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial
|
Nachman, Sharon
|
|
|
5 |
12 |
p. e715-e722
|
artikel
|
| 17 |
Taking Malawi's option B+ programme from a B+ to an A+
|
Rosenberg, Nora E
|
|
|
5 |
12 |
p. e672-e673
|
artikel
|
| 18 |
The art of expanding HIV awareness
|
Martin, Colin
|
|
|
5 |
12 |
p. e687
|
artikel
|
| 19 |
This is a story about living—not dying
|
Ranscombe, Peter
|
|
|
5 |
12 |
p. e686
|
artikel
|
Tijdschrift beschrijving